Estetrol for treatment of advanced ER+/HER2-breast cancer

被引：3
|
作者：
Schmidt, Marcus [1 ]
Hoenig, Arnd [2 ]
Zimmerman, Yvette [3 ]
Verhoeven, Carole [3 ]
Almstedt, Katrin [1 ]
Battista, Marco [1 ]
Lenhard, Hans Georg [2 ]
Krijgh, Jan [3 ]
Bennink, Herjan Coelingh [3 ]
机构：
[1] Univ Med Ctr, Mainz, Germany
[2] Catholic Hosp, Mainz, Germany
[3] Pantarhei Oncol, Zeist, Netherlands
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P5-11-15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-11-15
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2-breast cancer patients
    Dubsky, P.
    Brase, J. C.
    Jakesz, R.
    Rudas, M.
    Singer, C. F.
    Greil, R.
    Dietze, O.
    Luisser, I.
    Klug, E.
    Sedivy, R.
    Bachner, M.
    Mayr, D.
    Schmidt, M.
    Gehrmann, M. C.
    Petry, C.
    Weber, K. E.
    Fisch, K.
    Kronenwett, R.
    Gnant, M.
    Filipits, M.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 109 (12) : 2959 - 2964
  • [42] Identification of proteomics-based biomarkers for ER+/HER2-breast cancer stratification: Implications on clinical outcome
    Wang, Guisong
    Shah, Punit
    Searfoss, Rick
    Campbell, J. Leigh Fantacone
    Hooke, Jeffrey A.
    Deyarmin, Brenda
    Zingmark, Rebecca N.
    Somiari, Stella
    Liu, Jianfang
    Kvecher, Leonid
    Sturtz, Lori A.
    Raj-Kumar, Praveen-Kumar
    Granger, Elder
    Vahdat, Linda
    Cutler, Mary L.
    Sarangarajan, Rangaprasad
    Hu, Hai
    Kiebish, Michael A.
    Kovatich, Albert J.
    Narain, Niven R.
    Shriver, Craig D.
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [43] Outcome without any adjuvant systemic treatment in stage I ER+/HER2-breast cancer patients included in the MINDACT trial
    Cardozo, J. M. N. Lopes
    Byng, D.
    Drukker, C. A.
    Schmidt, M. K.
    Binuya, M. A.
    Veer, L. J. van 't
    Cardoso, F.
    Piccart, M.
    Smorenburg, C. H.
    Poncet, C.
    Rutgers, E. J. T.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (03) : 310 - 320
  • [44] Prognostic value of breast MRI characteristics before and during neoadjuvant endocrine therapy in patients with ER+/HER2-breast cancer
    Ragusi, Max A. A.
    Winter-Warnars, Gonneke A. O.
    Wesseling, Jelle
    Linn, Sabine C.
    Beets-Tan, Regina G.
    van der Velden, Bas H. M.
    Elias, Sjoerd G.
    Gilhuijs, Kenneth G. A.
    Loo, Claudette E.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1123):
  • [45] Wise and skillful utilization of contemporary endocrine therapies for the treatment of ER+/HER2- advanced breast cancer
    Wysocki, J.
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (04): : 291 - 301
  • [46] Decentral gene expression analysis for ER+/Her2-breast cancer: results of a proficiency testing program for the EndoPredict assay
    Denkert, Carsten
    Kronenwett, Ralf
    Schlake, Werner
    Bohmann, Kerstin
    Penzel, Roland
    Weber, Karsten E.
    Hoefler, Heinz
    Lehmann, Ulrich
    Schirmacher, Peter
    Specht, Katja
    Rudas, Margaretha
    Kreipe, Hans-Heinrich
    Schraml, Peter
    Schlake, Gudrun
    Bago-Horvath, Zsuzsanna
    Tiecke, Frank
    Varga, Zsuzsanna
    Moch, Holger
    Schmidt, Marcus
    Prinzler, Judith
    Kerjaschki, Dontscho
    Sinn, Bruno Valentin
    Mueller, Berit Maria
    Filipits, Martin
    Petry, Christoph
    Dietel, Manfred
    [J]. VIRCHOWS ARCHIV, 2012, 460 (03) : 251 - 259
  • [47] Defining the transcriptional and biological response to CDK4/6 inhibition in relation to ER+/HER2-breast cancer
    Knudsen, Erik S.
    Witkiewicz, Agnieszka K.
    [J]. ONCOTARGET, 2016, 7 (43) : 69111 - 69123
  • [48] Endoxifen Downregulates AKT Phosphorylation Through Protein Kinase C Beta 1 in ER+/HER2-Breast Cancer
    Jayaraman, Swaathi
    Wu, Xinyan
    Kalari, Krishna R.
    Tang, Xiaojia
    Kuffel, Mary
    Bruinsma, Elizabeth S.
    Renuse, Santosh
    Ingle, James N.
    Reid, Joel
    Schellenberg, Matthew
    Hawse, John
    Pandey, Akhilesh
    Goetz, Matthew P.
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [49] ASO Author Reflections: Considerations in the Debate on Sentinel Node Biopsy in Older Patients with ER+/Her2-Breast Cancer
    Chung, Alice
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (5) : 3198 - 3199
  • [50] Establishment of primary tumor models of TNBC and ER+/HER2-breast cancer in humanized mice and validation of pembrolizumab efficacy
    Kahkonen, Tiina E.
    Suominen, Mari I.
    Maki-Jouppila, Jenni He
    Tanaka, Azusa
    Dube, Philip
    Seiler, Michael
    Halleen, Jussi M.
    Bernoulli, Jenni
    [J]. MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
12345